On the past, present and future of senotherapeutics

During the first senotherapeutics conference organized by the Phaedon Institute at the Buck Institute for Research on Aging (Novato, CA), experts on the molecular and cellular mechanisms of aging, pathogenesis of age-related diseases, and drug discovery and development convened to delve into ideas on the past, present, and future of targeting senescent cells. The summit was divided into four sessions: basic biology, preclinical, clinical, and early-stage companies. Panel discussions covering large pharma, biomarkers, and investments in the field were organized between sessions.